OBJECTIVE: To determine the frequency, characteristics and outcomes of severe agitation among ventilated medical intensive care unit (MICU) patients. DESIGN: Prospective cohort study. SETTING: Eighteen-bed MICU in 964-bed tertiary care center. PATIENTS: All ventilated patients, aged 18 years or older and admitted for more than 24 h between January 1, 2001 and May 8, 2001. INTERVENTIONS: None. MEASUREMENTS: Data were collected daily by concurrent chart abstractions. Variables included sociodemographic, clinical, laboratory, pharmacologic and non-pharmacologic interventions, ventilator settings and adverse events. Severe agitation, the main outcome variable, was defined as two or more Motor Activity Assessment Scale (MAAS) scores above 4 in a 24-h period and sedative and/or narcotic doses above the established sedation and analgesia protocol or a combination of two or more sedatives. RESULTS: Twenty-three (16.1%) of 143 enrolled patients exhibited severe agitation. Agitated patients were younger (hazard ratio [HR] 1.32), more likely to be admitted from an outside hospital ICU (HR 2.48), had lower pH (HR 1.55) and PaO(2)/FIO(2) less than 200 mmHg (HR 2.59). Agitated patients had longer MICU stays (median 12 versus 5 days, p<0.0001) and more ventilator days (median 14 versus 6, p<0.0001). Agitated patients were more likely to self-extubate (26% versus 6%, p=0.002). Benzodiazepines, narcotics and neuromuscular blocking agents were administered more frequently and at higher doses, but haloperidol was not. CONCLUSION: Severe agitation occurs commonly in critically ill patients and is associated with adverse events including longer ICU stays, duration of mechanical ventilation and self-extubation.
OBJECTIVE: To determine the frequency, characteristics and outcomes of severe agitation among ventilated medical intensive care unit (MICU) patients. DESIGN: Prospective cohort study. SETTING: Eighteen-bed MICU in 964-bed tertiary care center. PATIENTS: All ventilated patients, aged 18 years or older and admitted for more than 24 h between January 1, 2001 and May 8, 2001. INTERVENTIONS: None. MEASUREMENTS: Data were collected daily by concurrent chart abstractions. Variables included sociodemographic, clinical, laboratory, pharmacologic and non-pharmacologic interventions, ventilator settings and adverse events. Severe agitation, the main outcome variable, was defined as two or more Motor Activity Assessment Scale (MAAS) scores above 4 in a 24-h period and sedative and/or narcotic doses above the established sedation and analgesia protocol or a combination of two or more sedatives. RESULTS: Twenty-three (16.1%) of 143 enrolled patients exhibited severe agitation. Agitated patients were younger (hazard ratio [HR] 1.32), more likely to be admitted from an outside hospital ICU (HR 2.48), had lower pH (HR 1.55) and PaO(2)/FIO(2) less than 200 mmHg (HR 2.59). Agitated patients had longer MICU stays (median 12 versus 5 days, p<0.0001) and more ventilator days (median 14 versus 6, p<0.0001). Agitated patients were more likely to self-extubate (26% versus 6%, p=0.002). Benzodiazepines, narcotics and neuromuscular blocking agents were administered more frequently and at higher doses, but haloperidol was not. CONCLUSION: Severe agitation occurs commonly in critically illpatients and is associated with adverse events including longer ICU stays, duration of mechanical ventilation and self-extubation.
Authors: N R MacIntyre; D J Cook; E W Ely; S K Epstein; J B Fink; J E Heffner; D Hess; R D Hubmayer; D J Scheinhorn Journal: Chest Date: 2001-12 Impact factor: 9.410
Authors: Michael J Murray; Jay Cowen; Heidi DeBlock; Brian Erstad; Anthony W Gray; Ann N Tescher; William T McGee; Richard C Prielipp; Greg Susla; Judith Jacobi; Stanley A Nasraway; Philip D Lumb Journal: Crit Care Med Date: 2002-01 Impact factor: 7.598
Authors: E W Ely; S K Inouye; G R Bernard; S Gordon; J Francis; L May; B Truman; T Speroff; S Gautam; R Margolin; R P Hart; R Dittus Journal: JAMA Date: 2001-12-05 Impact factor: 56.272
Authors: E W Ely; S Gautam; R Margolin; J Francis; L May; T Speroff; B Truman; R Dittus; R Bernard; S K Inouye Journal: Intensive Care Med Date: 2001-11-08 Impact factor: 17.440
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Bridgette Kram; Shawn J Kram; Michelle L Sharpe; Michael L James; Maragatha Kuchibhatla; Mark L Shapiro Journal: Anesth Analg Date: 2017-03 Impact factor: 5.108